Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiaozhi Qinggan Capsule in Nonalcoholic Simple Fatty Liver Disease
CTR20132184Phase 2Active
- Sponsor
- Jilin Province Beiyao Pharmaceutical Material Station
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tiaozhi Qinggan in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Jilin Province Beiyao Pharmaceutical Material Station. Started Mar 2014; status: active.
02
Drugs
Tiaozhi Qinggan
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on CTR20132184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132184.